Clinical Trials in Phoenix

Showing 4921-4940 of 16,646 trials

BIOTRONIK Conduction System Pacing With the Solia Lead

NCT05251363

The purpose of the BIO-CONDUCT study is to demonstrate the safety and effectiveness of the BIOTRONIK Solia S pacing lead when implanted in the left bundle branch (LBB) area. Safety will be assessed by evaluating serious adverse device effects that occur through 3 months post-implant. Efficacy will be assessed by evaluating implant success rate.

BradycardiaAtrioventricular BlockLeft Bundle-Branch Block+1 more

Biotronik, Inc.194 participantsStarted Dec 2022

Phoenix, Arizona, United States • Ventura, California, United States • Washington D.C., District of Columbia, United States +11 more locations

COMPLETEDPhase 1/2< 1 mile

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

NCT04761198

This is an open-label, phase 1b/2, multicenter study designed to evaluate the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics of etigilimab in combination with nivolumab in participants with locally advanced or metastatic solid tumors. Participants will be assigned to receive etigilimab (every 2 weeks) in combination with nivolumab (240 milligrams \[mg\] every 2 weeks).

Solid Tumor, AdultAdvanced Solid TumorMetastatic Solid Tumor

Mereo BioPharma76 participantsStarted Mar 2021

Phoenix, Arizona, United States • Greenbrae, California, United States • Los Angeles, California, United States +13 more locations

BIOTRONIK Conduction System Pacing With the Solia Lead

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

Find Trials by Condition in Phoenix

Study of Sonodynamic Therapy in Participants with Recurrent High-Grade Glioma

A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer

An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy Participants

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy

Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

A Study of LY3561774 in Participants With Mixed Dyslipidemia

A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor

A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease